Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding and Linkage00:49

Ligand Binding and Linkage

4.9K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.9K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

1.2K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular Views into the Synthesis and Activation of Flavocytochrome <i>b</i><sub>558</sub> in Phagocytic Cells-Focus on the Role of EROS.

Antioxidants (Basel, Switzerland)·2026
Same author

Hemagglutinin double-mutation enhances binding of human-infecting avian influenza virus clade 2.3.4.4b H5Ny to human and SLe<sup>X</sup> receptors.

EMBO reports·2026
Same author

A long-chain heparan sulfate capture mechanism directs paracrine GDNF-GFRα1 signalling through RET.

bioRxiv : the preprint server for biology·2026
Same author

Synthesis of Sulfated Glycomimetics with Micromolar Affinity for Midkine.

The Journal of organic chemistry·2026
Same author

Enhancing lectin recognition via precise fluorination: Man<sub>5</sub> glycomimetics for targeting DC-SIGN.

Bioorganic chemistry·2026
Same author

Azobenzene-bridged ionizable amphiphilic Janus glycosides for light-controlled, single-component and organ-modulable pDNA delivery.

Communications chemistry·2026
Same journal

Bi-modified Ni<sub>3</sub>S<sub>2</sub> promotes selective nitrite-to-hydroxylamine reduction for cyclohexanone oxime synthesis.

Chemical communications (Cambridge, England)·2026
Same journal

Cyclable manganese inventory as a mechanistic descriptor for electrolyte design in rechargeable aqueous Zn-MnO<sub>2</sub> batteries.

Chemical communications (Cambridge, England)·2026
Same journal

Cobalt-iron layered double hydroxides with ligand modification for boosting glycerol electrooxidation-assisted hydrogen production.

Chemical communications (Cambridge, England)·2026
Same journal

Beyond the vacuum: modeling the solid-liquid interface for gas-involving electrocatalysis.

Chemical communications (Cambridge, England)·2026
Same journal

Alkaline-earth carbonate-supported Ru for quinoline hydrogenation: enhanced H<sub>2</sub> activation <i>via</i> electronic metal-support interaction.

Chemical communications (Cambridge, England)·2026
Same journal

Mitigating ionic conductivity limitations <i>in operando</i> electrochemical X-ray photoelectron spectroscopy.

Chemical communications (Cambridge, England)·2026
See all related articles

Related Experiment Video

Updated: Aug 26, 2025

Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy
12:24

Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy

Published on: September 29, 2016

7.1K

Mannobioside biomimetics that trigger DC-SIGN binding selectivity.

Irene Herrera-González1, Michel Thépaut2, Elena M Sánchez-Fernández1

  • 1Department of Organic Chemistry, Faculty of Chemistry, University of Seville, C/Profesor García González 1, Seville 41012, Spain. mellet@us.es.

Chemical Communications (Cambridge, England)
|October 11, 2022
PubMed
Summary
This summary is machine-generated.

Multivalent sp2-iminosugar mannobioside analogs selectively target DC-SIGN, not langerin. These biomimetic compounds offer potential as novel anti-infective agents by mimicking natural ligand binding.

More Related Videos

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
10:17

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library

Published on: January 14, 2020

7.8K
Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
11:04

Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides

Published on: September 7, 2019

9.3K

Related Experiment Videos

Last Updated: Aug 26, 2025

Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy
12:24

Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy

Published on: September 29, 2016

7.1K
Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
10:17

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library

Published on: January 14, 2020

7.8K
Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
11:04

Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides

Published on: September 7, 2019

9.3K

Area of Science:

  • Carbohydrate chemistry
  • Immunology
  • Infectious diseases

Background:

  • Dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) and langerin are C-type lectins involved in pathogen recognition.
  • Targeting these receptors offers a potential strategy for developing anti-infective agents.
  • These lectins have counteracting effects during infections by certain pathogens.

Purpose of the Study:

  • To investigate the development of selective DC-SIGN targeting agents.
  • To explore the potential of multivalent sp2-iminosugar-containing mannobioside analogs as biomimetic ligands.
  • To assess the selectivity of these analogs towards DC-SIGN over langerin.

Main Methods:

  • Synthesis of multivalent sp2-iminosugar-containing mannobioside analogs.
  • Evaluation of binding affinity and selectivity towards DC-SIGN and langerin.
  • Utilizing the canonical binding mode of high-mannose oligosaccharide ligands.

Main Results:

  • The synthesized mannobioside analogs demonstrated complete selectivity for DC-SIGN.
  • These analogs effectively mimicked the binding of natural high-mannose oligosaccharide ligands.
  • The compounds leveraged the canonical binding mode for selective receptor interaction.

Conclusions:

  • Multivalent sp2-iminosugar mannobioside analogs can achieve exclusive DC-SIGN targeting.
  • These findings support the development of DC-SIGN selective agents.
  • The biomimetic approach offers a promising avenue for novel anti-infective therapies.